EUVIMEDEUVIMED entdecken
Crossref

Correlates of Healthcare Patients’ Interest in and Use of Medication and Non-Evidence-Based Approaches to Weight Loss

Francesca L Wilkins iD, Wendy S Moore, Jalen R Jackson, Megan A McVay iD

American Journal of Health Promotion · 2025

DOI: 10.1177/08901171251392887 ↗

Kurz gefasst

Fachartikel in der Zeitschrift American Journal of Health Promotion, 2025. Verfasst von Francesca L Wilkins und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Health Education & Behavior, University of Florida, Gainesville, FL, USA. Hauptthemen laut MEDLINE: Weight Loss, Obesity. Die Arbeit nennt 76 Literaturangaben. Gefördert von: University of Florida College of Health & Human Performance.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Purpose

Explore correlates of interest in and use of non-evidence-based practices (e.g., supplements, home remedies) and glucagon-like peptide-1 (GLP-1s) for weight loss.

Design

Online cross-sectional survey.

Setting

Healthcare patients of a large academic health system in the Southeast United States. Sample Patients (N = 190) with BMI ≥30 kg/m 2 . Measures Interest in and past use of non-evidence-based practices and GLP-1s for obesity, and psychosocial factors, such as distrust in pharmaceutical corporations, preference for naturalness (i.e., favoring approaches described as natural over conventional medications), and expected weight loss were measured. Analysis Bivariate associations and multivariable regressions.

Results

Interest in non-evidence-based practices was greater among women and Black/African American patients ( P < 0.05) and positively associated with perception of social norms for use ( P < 0.01) and weight loss expectations with use ( P < 0.05). Past use of non-evidence-based practices was associated with greater pharmaceutical distrust ( P < 0.05). Interest in GLP-1s was associated with lower education ( P < 0.05) and naturalness preference ( P < 0.01), and greater social norms ( P < 0.001), weight risk perceptions, and weight loss expectations ( P < 0.05). Past use of GLP-1s was associated with lower expected weight loss with GLP-1s ( P < 0.05).

Conclusion

Findings can inform patient education to help steer patients towards evidence-based treatments and away from ineffective approaches.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Weight LossObesityHumansFemaleMaleCross-Sectional StudiesMiddle AgedAdultGlucagon-Like Peptide 1AgedDietary Supplements

Stichwörter der Autor:innen

dietary supplementsglucagon-like peptidesobesityweight loss

Substanzen

Glucagon-Like Peptide 1

Autor:innen und Institutionen

  • Department of Health Education & Behavior, University of Florida, Gainesville, FL, USA.
  • Center for Integrative Cardiovascular and Metabolic Disease, University of Florida, Gainesville, FL, USA.

ORCID-Profile: Francesca L Wilkins, Megan A McVay

Förderung

  • University of Florida College of Health & Human Performance

Zitieren

APA

Wilkins, F. L., Moore, W. S., Jackson, J. R., & McVay, M. A. (2025). Correlates of Healthcare Patients’ Interest in and Use of Medication and Non-Evidence-Based Approaches to Weight Loss. American Journal of Health Promotion. https://doi.org/10.1177/08901171251392887

Vancouver

Wilkins FL, Moore WS, Jackson JR, McVay MA. Correlates of Healthcare Patients’ Interest in and Use of Medication and Non-Evidence-Based Approaches to Weight Loss. American Journal of Health Promotion. 2025. doi:10.1177/08901171251392887

BibTeX
@article{Wilkins2025,
  author = {Wilkins, Francesca L and Moore, Wendy S and Jackson, Jalen R and McVay, Megan A},
  title = {Correlates of Healthcare Patients’ Interest in and Use of Medication and Non-Evidence-Based Approaches to Weight Loss},
  journal = {American Journal of Health Promotion},
  year = {2025},
  doi = {10.1177/08901171251392887}
}
Kostenlos starten →